Trial Profile
A Safety and Efficacy Study of ALPHAGAN P and LUMIGAN in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2015
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary) ; Brimonidine (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 09 Apr 2015 New trial record